| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |